A new study conducted by the Global Neuroscience Initiative Foundation in Los Angeles suggests that cannabis can significantly reduce spasticity in multiple sclerosis (MS) patients.
Researchers reviewed six separate studies where marijuana was used in MS patients, and found that five of the trials showed that the use of the drug reduced spasms and involuntary muscle tension while improving the individual’s mobility.
"The therapeutic potential of cannabinoids in MS appears to be comprehensive, and should be given considerable attention," said lead researcher Shaheen Lakhan.
Lakhan stated that current conventional treatments may also reduce spasticity, but can be ineffective, difficult to obtain or associated with painful side-effects.
Researchers do warn of potential repercussions of the use of medicinal marijuana, such as intoxication or addiction, but they add that "considering the distress and limitations spasticity brings to individuals with MS, it is important to carefully weigh the potential for side effects with the potential for symptom relief."
Meanwhile, independent research has indicated that medicinal marijuana may also be helpful in controlling symptoms associated with glaucoma and certain forms of cancer.